https://endeavourvision.com/news/ 2026-05-12T21:43:54+00:00 https://endeavourvision.com/cequr-raises-115-million-series-c5-financing/ 2022-01-27T22:12:23+00:00 https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/nalu-medical-inc-names-thomas-west-president-and-chief-executive-officer/ 2023-02-22T12:06:39+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/intelycare-secures-115-million-series-c-financing-led-by-janus-henderson-investors/ 2023-02-22T12:11:07+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/nalu-medical-inc-announces-104-million-equity-financing/ 2023-02-22T12:13:33+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/intelycare-hires-key-c-level-executives-continues-u-s-expansion-after-tripling-revenue-in-2021-and-seeing-continued-growth-in-q1/ 2023-02-22T12:18:03+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/relievant-medsystems-announces-appointment-of-dave-amerson-to-board-of-directors/ 2023-02-22T12:34:34+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/relievant-medsystems-names-tyler-binney-president-and-ceo/ 2023-02-22T12:37:13+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/neurovascular-technology-qa-with-endeavour-visions-investment-manager-toby-auwerter/ 2023-03-28T13:18:15+00:00 https://endeavourvision.com/wp-content/uploads/2023/03/news-featured-image_toby-auwerter-.jpg https://endeavourvision.com/wp-content/uploads/2016/03/news-endeavour-vision.jpg https://endeavourvision.com/the-innovation-continues-for-robotic-assisted-surgery/ 2023-03-28T13:20:01+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/miach-orthopaedics-secures-40-million-financing/ 2023-03-28T13:20:57+00:00 https://endeavourvision.com/wp-content/uploads/2023/01/news-featured-img_Miach_700x447.jpg https://endeavourvision.com/wp-content/uploads/2023/01/news-featured-img_Miach_700x447.jpg https://endeavourvision.com/healthjoy-raises-60m-series-d-to-power-hr-leaders-through-a-new-era-of-workplace-and-healthcare-benefits/ 2023-03-28T13:41:47+00:00 https://endeavourvision.com/wp-content/uploads/2022/10/news-featured-img_JealthJoy_700x447.jpg https://endeavourvision.com/wp-content/uploads/2022/10/news-featured-img_JealthJoy_700x447.jpg https://endeavourvision.com/endeavour-vision-adds-kestra-medical-technologies-to-emg-ii-portfolio/ 2023-03-28T13:42:45+00:00 https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/intelycare-announces-900000-enrollments-in-intelyedu-empowering-nursing-professionals-with-affordable-innovative-access-to-continuing-education/ 2023-03-28T13:43:18+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/flex-vessel-prep-av-registry-data-shows-a-longer-lasting-solution-to-stand-alone-pta-when-treating-av-access-fistulas-and-grafts/ 2023-03-28T13:44:46+00:00 https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/care-tech-startup-kenbi-raises-e23-5m-series-a-to-scale-its-homecare-network/ 2023-03-28T13:47:48+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_kenbi_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_kenbi_700x447_2.jpg https://endeavourvision.com/virtual-incision-announces-approval-to-complete-clinical-study-enrollment-for-its-mira-platform/ 2023-03-28T13:49:36+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/virtual-incision-announces-46-million-financing-to-advance-first-of-its-kind-mira-surgical-platform/ 2023-03-28T13:51:24+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/femtech-leader-willow-adds-diverse-set-of-investors-in-extended-series-c-round/ 2023-03-28T13:52:39+00:00 https://endeavourvision.com/wp-content/uploads/2021/05/news-featured-img_willow_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/05/news-featured-img_willow_700x447_2.jpg https://endeavourvision.com/rd-100-award-for-it-electrical-technology-is-fourth-prestigious-win-for-nalu-medical/ 2023-03-28T13:56:16+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/endeavour-vision-closes-endeavour-medtech-growth-ii-lp-at-usd-375m/ 2023-03-28T14:01:18+00:00 https://endeavourvision.com/wp-content/uploads/2021/04/EV_FundClosing_website_600x383.jpg https://endeavourvision.com/wp-content/uploads/2021/04/EV_FundClosing_website_600x383.jpg https://endeavourvision.com/how-do-we-invest-in-quality-of-life-interview/ 2023-03-29T07:41:43+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/Quality-of-life-news_700x441_3white.jpg https://endeavourvision.com/wp-content/uploads/2021/12/Quality-of-life-news_700x441_3white.jpg https://endeavourvision.com/venturemed-group-raises-15-million-series-b-equity-financing/ 2023-03-29T07:46:46+00:00 https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/william-t-abraham-md-joins-v-wave-as-chief-medical-officer/ 2023-03-29T07:50:51+00:00 https://endeavourvision.com/wp-content/uploads/2019/03/news-header-v-wave-02.jpg https://endeavourvision.com/wp-content/uploads/2019/03/news-header-v-wave-02.jpg https://endeavourvision.com/cequr-appoints-rick-doubleday-and-dr-meret-gaugler-to-board-of-directors/ 2023-03-29T07:55:53+00:00 https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/interview-with-endeavour-visions-senior-investment-director-daniel-van-den-bergh/ 2023-03-29T15:18:00+00:00 https://endeavourvision.com/wp-content/uploads/2022/02/news-featured-image_DanielVdBergh-EV700x448.jpg http://endeavourvision.com/wp-content/uploads/2022/02/news-featured-image_DanielVdBergh-EV700x448.jpg https://endeavourvision.com/relievant-medsystems-announces-publication-of-new-intracept-trial-data-demonstrating-long-term-relief-for-chronic-low-back-pain-24-months-post-procedure/ 2023-03-29T15:22:36+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_relievant_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_relievant_700x447_2.jpg https://endeavourvision.com/relievant-medsystems-announces-highest-quality-of-evidence-ranking-for-basivertebral-nerve-ablation-in-aspn-back-guideline-for-interventional-low-back-pain-treatments/ 2023-03-30T13:43:26+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_relievant_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_relievant_700x447_2.jpg https://endeavourvision.com/interview-with-tyler-binney-ceo-of-relievant/ 2023-03-30T14:21:22+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/CEO-and-LOGO_Relievant_400x255.jpg http://endeavourvision.com/wp-content/uploads/2021/11/CEO-and-LOGO_Relievant_400x255.jpg https://endeavourvision.com/clint-carnell-named-ceo-of-inbrace/ 2023-03-30T14:28:33+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/CEO-and-LOGO_InBrace_ClintCarnell-1.jpg https://endeavourvision.com/wp-content/uploads/2021/11/CEO-and-LOGO_InBrace_ClintCarnell-1.jpg https://endeavourvision.com/inbrace-raises-102m-series-d-financing/ 2023-03-30T14:35:57+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_inbrace_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_inbrace_700x447_2.jpg https://endeavourvision.com/lumeon-announces-appointment-of-breht-feigh-as-chief-financial-officer-as-company-shows-strong-momentum/ 2023-03-30T14:39:38+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_lumenon_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/08/news-featured-image_lumeon2.jpg https://endeavourvision.com/lumeon-raises-30m-in-funding-to-support-u-s-growth/ 2023-03-30T14:41:20+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_lumenon_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_lumenon_700x447_2.jpg https://endeavourvision.com/sophia-genetics-announces-pricing-of-initial-public-offering/ 2023-03-30T14:43:22+00:00 https://endeavourvision.com/wp-content/uploads/2021/07/news-featured-img_sophia_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/07/news-featured-img_sophia_700x447_2.jpg https://endeavourvision.com/interview-with-jurgi-camblong-ceo-of-sophia-genetics/ 2023-03-30T14:46:17+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/CEO-and-LOGO_Sophia.jpg https://endeavourvision.com/wp-content/uploads/2020/12/CEO-and-LOGO_Sophia.jpg https://endeavourvision.com/sophia-genetics-raises-110-million-in-oversubscribed-new-funding-round/ 2023-03-30T14:50:15+00:00 https://endeavourvision.com/wp-content/uploads/2021/07/news-featured-img_sophia_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/07/news-featured-img_sophia_700x447_2.jpg https://endeavourvision.com/rapid-micro-biosystems-announces-appointment-of-melinda-litherland-to-board-of-directors/ 2023-03-30T14:56:22+00:00 https://endeavourvision.com/wp-content/uploads/2021/08/news-featured-img_rapidmicro_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/08/news-featured-img_rapidmicro_700x447_2.jpg https://endeavourvision.com/rapid-micro-biosystems-announces-pricing-of-initial-public-offering/ 2023-03-30T15:03:42+00:00 https://endeavourvision.com/wp-content/uploads/2020/05/news-rapid-micro-biosystems.jpg https://endeavourvision.com/wp-content/uploads/2020/05/news-rapid-micro-biosystems.jpg https://endeavourvision.com/rapid-micro-biosystems-raises-81m-to-continue-global-expansion/ 2023-03-30T15:09:44+00:00 https://endeavourvision.com/wp-content/uploads/2020/05/CEO_RMB.jpg https://endeavourvision.com/wp-content/uploads/2020/05/CEO_RMB.jpg https://endeavourvision.com/nuvaira-announces-chief-financial-officer-and-pivotal-study-milestone/ 2023-03-30T15:14:32+00:00 https://endeavourvision.com/wp-content/uploads/2020/02/news-featured-img_nuvaira_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/02/news-featured-img_nuvaira_700x447_2.jpg https://endeavourvision.com/interview-with-dennis-wahr-president-and-ceo-nuvaira/ 2023-03-30T15:18:33+00:00 https://endeavourvision.com/wp-content/uploads/2020/01/Dennis-Wahr-NUVAIRA.jpg https://endeavourvision.com/wp-content/uploads/2020/01/Dennis-Wahr-NUVAIRA.jpg https://endeavourvision.com/v-wave-receives-second-fda-breakthrough-device-designation-interatrial-shunt-for-pulmonary-arterial-hypertension/ 2023-04-03T08:29:11+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-vwave_shunt_2019_1.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-vwave_shunt_2019_1.jpg https://endeavourvision.com/v-waves-interatrial-shunt-receives-fda-breakthrough-device-designation-for-heart-failure/ 2023-04-03T10:08:50+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-vwave_shunt_2019_1.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-vwave_shunt_2019_1.jpg https://endeavourvision.com/interview-with-bradley-paddock-ceo-of-cequr-2/ 2023-04-03T10:12:07+00:00 https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/medartis-completes-acquisition-of-nextremity-solutions-inc-and-announces-new-us-leadership/ 2023-04-03T10:19:57+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/gynesonics-names-robert-brown-chief-financial-officer/ 2023-04-03T10:41:18+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/blackhawk-network-acquires-germany-based-prepaid-leader-retailo-as-part-of-ongoing-international-expansion-strategy/ 2023-04-03T11:51:49+00:00 https://endeavourvision.com/wp-content/uploads/2013/12/news-blackhawk-network.jpg https://endeavourvision.com/medartis-appoints-dirk-kirsten-as-chief-financial-officer/ 2023-04-03T11:55:38+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/medartis-nominates-marco-gadola-for-election-to-the-board-of-directors/ 2023-04-03T12:05:14+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/boston-scientific-announces-agreement-to-acquire-vertiflex-inc/ 2023-04-03T12:10:30+00:00 https://endeavourvision.com/wp-content/uploads/2019/05/news-header-vertiflex.jpg https://endeavourvision.com/wp-content/uploads/2019/05/news-header-vertiflex.jpg https://endeavourvision.com/vertiflex-announces-appointments-to-board-of-directors-ray-baker-md-and-richard-mott/ 2023-04-03T12:11:42+00:00 https://endeavourvision.com/wp-content/uploads/2018/06/news-vertiflex-2018-11.jpg https://endeavourvision.com/wp-content/uploads/2018/06/news-vertiflex-2018-11.jpg https://endeavourvision.com/vertiflex-inc-completes-40-million-financing-round-pma-approved-superion-demonstrating-early-commercial-successv-waves-interatrial-shunt-receives-fda-breakthrough-device-designation-for-heart/ 2023-04-03T12:13:41+00:00 https://endeavourvision.com/wp-content/uploads/2019/05/news-header-vertiflex.jpg https://endeavourvision.com/wp-content/uploads/2019/05/news-header-vertiflex.jpg https://endeavourvision.com/new-guidance-from-the-american-college-of-obstetricians-and-gynecologists-for-fibroid-management/ 2023-04-03T12:16:14+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/gynesonics-announces-positive-payer-coverage-issued-by-health-care-service-corporation-hcsc-for-the-sonata-treatment/ 2023-04-03T12:21:46+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/polares-medical-closes-a-40m-financing-to-complete-pilot-clinical-studies/ 2023-04-03T12:27:32+00:00 https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-img_polares_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-img_polares_700x447_2.jpg https://endeavourvision.com/symetis-grows-and-invests-on-its-ecublens-site-article-from-agefi/ 2023-04-03T12:36:38+00:00 https://endeavourvision.com/wp-content/uploads/2018/06/news-symetis-2018-10.jpg https://endeavourvision.com/wp-content/uploads/2018/06/news-symetis-2018-10.jpg https://endeavourvision.com/symetis-launches-its-ipo-on-euronext-paris/ 2023-04-03T12:39:50+00:00 https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/symetis-launches-e55m-ipo-for-artificial-heart-valves/ 2023-04-03T12:42:27+00:00 https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/intelycare-adds-uber-and-google-executives-to-its-board-in-support-of-unprecedented-revenue-growth/ 2023-04-03T12:48:19+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/gynesonics-announces-publication-of-choices-a-comparative-study-of-the-sonata-treatment-versus-myomectomy/ 2023-04-03T12:54:00+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/inc-magazine-unveils-its-annual-list-of-americas-fastest-growing-private-companies-the-inc-5000/ 2023-04-03T12:56:24+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/relievant-medsystems-announces-70m-financing-to-accelerate-u-s-commercialization-of-intracept-procedure/ 2023-04-03T13:08:01+00:00 https://endeavourvision.com/wp-content/uploads/2020/10/RELIEVANT-400x255-1.jpg http://endeavourvision.com/wp-content/uploads/2020/10/RELIEVANT-400x255-1.jpg https://endeavourvision.com/sophia-genetics-expands-its-executive-team-naming-lara-hashimoto-chief-business-officer/ 2023-04-03T13:13:32+00:00 https://endeavourvision.com/wp-content/uploads/2020/04/news-sophia_2020_01.jpg https://endeavourvision.com/wp-content/uploads/2019/07/company-sophia-genetics-e1586444403884.jpg https://endeavourvision.com/sophia-genetics-raises-77-million-to-accelerate-the-democratization-of-data-driven-medicine/ 2023-04-03T13:34:52+00:00 https://endeavourvision.com/wp-content/uploads/2019/01/news-sophia_2019_21.jpg https://endeavourvision.com/wp-content/uploads/2019/01/news-sophia_2019_21.jpg https://endeavourvision.com/interview-with-robert-spignesi-ceo-of-rapid-micro-biosystems/ 2023-04-03T13:35:36+00:00 https://endeavourvision.com/wp-content/uploads/2020/05/CEO_RMB.jpg https://endeavourvision.com/wp-content/uploads/2020/05/CEO_RMB.jpg https://endeavourvision.com/sophia-genetics-acquires-interactive-biosoftware-to-drive-growth-and-accelerate-data-driven-medicine-adoption-around-the-world/ 2023-04-03T13:43:15+00:00 https://endeavourvision.com/wp-content/uploads/2018/06/news-sophia-2018-9.jpg https://endeavourvision.com/wp-content/uploads/2018/06/news-sophia-2018-9.jpg https://endeavourvision.com/sophia-genetics-achieves-ce-ivd-milestone/ 2023-04-03T13:48:22+00:00 https://endeavourvision.com/wp-content/uploads/2019/04/news-header-sophia.jpg https://endeavourvision.com/wp-content/uploads/2019/04/news-header-sophia.jpg https://endeavourvision.com/sophia-genetics-announces-ce-ivd-marking-of-its-genomic-test-for-leukemia-detection/ 2023-04-03T13:49:47+00:00 https://endeavourvision.com/wp-content/uploads/2018/02/news-sophia-2018-15.jpg https://endeavourvision.com/wp-content/uploads/2018/02/news-sophia-2018-15.jpg https://endeavourvision.com/intelycare-hires-david-burke-as-cfo-to-drive-business-growth-and-momentum-address-intensifying-staffing-demands-in-post-acute-space/ 2023-04-03T13:57:32+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/rapid-micro-biosystems-raises-120-million-to-accelerate-global-expansion-of-contaminant-testing-platform-for-pharmaceutical-and-vaccine-manufacturing/ 2023-04-03T14:13:17+00:00 https://endeavourvision.com/wp-content/uploads/2020/05/news-rapid-micro-biosystems.jpg https://endeavourvision.com/wp-content/uploads/2020/05/news-rapid-micro-biosystems.jpg https://endeavourvision.com/intelycare-announces-record-growth-and-momentum/ 2023-04-03T14:21:15+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/intelycare-sees-exceptional-momentum-and-growth-expands-leadership-team-and-employee-base-to-support-post-acute-market-and-nursing-professionals-amid-pandemic/ 2023-04-03T14:23:34+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/interview-with-david-coppins-ceo-of-intelycare/ 2023-04-03T14:27:35+00:00 https://endeavourvision.com/wp-content/uploads/2020/09/CEO-and-LOGO_Intelycare.jpg https://endeavourvision.com/wp-content/uploads/2020/09/CEO-and-LOGO_Intelycare-1.jpg https://endeavourvision.com/intelycare-launches-first-covid-19-training-program-for-nurses-nursing-facilities-to-help-mitigate-spread-of-virus/ 2023-04-03T14:34:31+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/endeavour-vision-leads-investment-in-intelycares-artificial-intelligence-driven-nurse-staffing-platform-to-support-the-next-phase-of-the-companys-growth/ 2023-04-03T14:41:08+00:00 https://endeavourvision.com/wp-content/uploads/2016/03/news-endeavour-vision.jpg https://endeavourvision.com/wp-content/uploads/2016/03/news-endeavour-vision.jpg https://endeavourvision.com/molecular-partners-receives-orphan-drug-designation-for-mp0250-for-multiple-myeloma/ 2023-04-03T14:45:04+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-header-molecular-partners-01.jpg https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/intelycare-completes-largest-venture-round-in-nursing-raises-45m-to-solve-nationwide-workforce-shortage/ 2023-04-03T14:50:36+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/gynesonics-announces-full-launch-of-new-sonata-2-system-at-48th-aagl-global-congress/ 2023-04-03T14:57:59+00:00 https://endeavourvision.com/wp-content/uploads/2018/08/news-gynesonics-2018-4.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/interview-with-bradley-paddock-ceo-of-cequr/ 2023-04-03T15:01:27+00:00 https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/relievant-announces-publication-of-smart-trial-24-month-results/ 2023-04-03T15:04:54+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-header-relievant-02.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-header-relievant-02.jpg https://endeavourvision.com/nuvaira-announces-a-79-million-financing-round-to-pursue-groundbreaking-treatment-of-copd/ 2023-04-03T15:11:44+00:00 https://endeavourvision.com/wp-content/uploads/2019/02/news-nuvaira__2019_17.jpg https://endeavourvision.com/wp-content/uploads/2019/02/news-nuvaira__2019_17.jpg https://endeavourvision.com/molecular-partners-provides-additional-details-on-clinical-studies-of-proprietary-lead-oncology-asset-mp0250/ 2023-04-03T15:19:13+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/enteromedics-announces-acquisition-of-reshape-medical/ 2023-04-05T08:38:29+00:00 https://endeavourvision.com/wp-content/uploads/2017/10/news-entero-Medics-reshape-lifesciences.jpg https://endeavourvision.com/wp-content/uploads/2017/10/news-entero-Medics-reshape-lifesciences.jpg https://endeavourvision.com/allergan-molecular-partners-announce-acceptance-of-u-s-fda-biologics-license-application-and-validation-of-ema-marketing-authorisation/ 2023-04-05T08:50:32+00:00 https://endeavourvision.com/wp-content/uploads/2019/09/news-allergan-molecular_2019_2.jpg https://endeavourvision.com/wp-content/uploads/2019/09/news-allergan-molecular_2019_2.jpg https://endeavourvision.com/allergan-and-molecular-partners-present-late-breaking-data-from-phase-3-studies-of-investigational-abicipar-pegol-in-neovascular-wet-age-related-macular-degeneration/ 2023-04-05T08:54:14+00:00 https://endeavourvision.com/wp-content/uploads/2019/09/news-allergan-molecular_2019_2.jpg https://endeavourvision.com/wp-content/uploads/2019/09/news-allergan-molecular_2019_2.jpg https://endeavourvision.com/molecular-partners-strategic-partner-allergan-announces-that-ema-has-validated-the-marketing-authorisation-application-for-abicipar/ 2023-04-05T09:32:29+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-header-molecular-partners-01.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-header-molecular-partners-01.jpg https://endeavourvision.com/relievant-announces-publication-of-positive-results-from-multi-center-study-of-the-intracept-procedure-in-real-world-setting-for-patients-with-chronic-low-back-pain/ 2023-04-06T09:28:15+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-relievant_2019_04.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-relievant_2019_04.jpg https://endeavourvision.com/gynesonics-announces-5-year-patient-outcomes-with-sonata-system/ 2023-04-06T09:33:27+00:00 https://endeavourvision.com/wp-content/uploads/2019/03/news-gynesonics_2019_19.jpg https://endeavourvision.com/wp-content/uploads/2019/03/news-gynesonics_2019_19.jpg https://endeavourvision.com/v-wave-closes-70m-financing-to-support-pivotal-study-of-its-heart-failure-therapy/ 2023-04-06T09:37:41+00:00 https://endeavourvision.com/wp-content/uploads/2018/04/news-vwave-2018-12.jpg https://endeavourvision.com/wp-content/uploads/2018/04/news-vwave-2018-12.jpg https://endeavourvision.com/enteromedics-announces-name-change-to-reshape-lifesciences-inc/ 2023-04-12T09:57:05+00:00 https://endeavourvision.com/wp-content/uploads/2017/10/news-featured-img_reshape_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2017/10/news-featured-img_reshape_700x447_2.jpg https://endeavourvision.com/pneumrx-acquired-by-btg-plc-for-up-to-usd-475-millionv-waves-interatrial-shunt-receives-fda-breakthrough-device-designation-for-heart-failure-2/ 2023-04-12T10:04:10+00:00 https://endeavourvision.com/wp-content/uploads/2014/12/news-featured-img_pneumrx_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2014/12/news-featured-img_pneumrx_700x447_2.jpg https://endeavourvision.com/quid-named-a-tech-pioneer-by-world-economic-forum/ 2023-04-12T10:13:33+00:00 https://endeavourvision.com/wp-content/uploads/2016/06/news-featured-img_netbasequid_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2016/06/news-featured-img_netbasequid_700x447_2.jpg https://endeavourvision.com/bind-therapeutics-enters-nanomedicine-collaboration-with-swiss-drug-giant/ 2023-04-12T10:19:33+00:00 https://endeavourvision.com/wp-content/uploads/2014/06/news-featured-img_bind_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2014/06/news-featured-img_bind_700x447_2.jpg https://endeavourvision.com/bind-therapeutics-announces-pricing-of-initial-public-offering/ 2023-04-12T10:22:59+00:00 https://endeavourvision.com/wp-content/uploads/2014/06/news-featured-img_bind_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2014/06/news-featured-img_bind_700x447_2.jpg https://endeavourvision.com/merck-acquires-oncoethix-a-privately-held-oncology-company-developing-novel-bet-inhibitors-for-hematological-and-solid-cancers/ 2023-04-12T11:29:27+00:00 https://endeavourvision.com/wp-content/uploads/2014/12/news-featured-img_oncoethix_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2014/12/news-featured-img_oncoethix_700x447_2.jpg https://endeavourvision.com/hgst-announces-definitive-agreement-to-acquire-amplidata/ 2023-04-12T11:35:51+00:00 https://endeavourvision.com/wp-content/uploads/2015/03/news-amplidata.jpg https://endeavourvision.com/cequr-appoints-bradley-paddock-chief-executive-officer/ 2023-04-12T11:40:58+00:00 https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/wp-content/uploads/2019/06/news-header-cequr-01.jpg https://endeavourvision.com/cequr-acquires-jjs-calibra-finesse-onetouch-via-bolus-patch-device/ 2023-04-12T11:45:09+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/news-cequr-02.jpg https://endeavourvision.com/wp-content/uploads/2018/07/news-cequr-02.jpg https://endeavourvision.com/cequr-sa-names-robert-oholla-evp-for-regulatory-affairs/ 2023-04-12T11:59:10+00:00 https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/gynesonics-announces-brigham-and-womens-faulkner-hospital-becomes-the-first-in-massachusetts-to-offer-innovative-new-procedure-to-treat-symptomatic-uterine-fibroids-2/ 2023-04-12T12:20:11+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/gynesonics-announces-publication-of-open-clinical-trial-results-demonstrating-no-intrauterine-adhesion-formation-following-treatment-with-the-sonata-system/ 2023-04-12T12:24:59+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/relievant-announces-publication-of-5-year-data-demonstrating-long-term-clinical-benefits-of-the-intracept-procedure-in-chronic-low-back-pain-patients/ 2023-04-12T12:30:05+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/wp-content/uploads/2018/07/Art-Taylor-RELIEVANT.jpg https://endeavourvision.com/gynesonics-announces-submission-of-fda-510k-for-incision-free-treatment-of-symptomatic-uterine-fibroids/ 2023-04-12T12:32:32+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/symetis-announces-a-symbolic-milestone-the-1000th-patient-implanted-with-acurate-ta/ 2023-04-12T12:38:34+00:00 https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/roche-and-molecular-partners-enter-into-alliance-to-develop-new-cancer-treatments-partnership-will-combine-novel-biologics-darpins-with-roche-drug-conjugate-technology/ 2023-04-12T12:47:31+00:00 https://endeavourvision.com/wp-content/uploads/2013/12/news-roche-molecular-partners.jpg https://endeavourvision.com/wp-content/uploads/2013/12/news-roche-molecular-partners.jpg https://endeavourvision.com/interview-with-chris-owens-ceo-president-at-gynesonics/ 2023-04-12T12:51:29+00:00 https://endeavourvision.com/wp-content/uploads/2019/05/news-gynesonics-chris-owens-02.jpg https://endeavourvision.com/wp-content/uploads/2019/05/news-gynesonics-chris-owens-02.jpg https://endeavourvision.com/medartis-achieves-one-of-the-largest-and-most-successful-ipos-in-the-field-of-medical-technology-in-2018-on-the-swiss-stock-exchange/ 2023-04-12T12:59:24+00:00 https://endeavourvision.com/wp-content/uploads/2018/12/news-medartis-2018-2.jpg https://endeavourvision.com/wp-content/uploads/2018/12/news-medartis-2018-2.jpg https://endeavourvision.com/medartis-ipo-funds-slated-to-support-expansion/ 2023-04-12T13:05:14+00:00 https://endeavourvision.com/wp-content/uploads/2018/03/news-medartis-2018-13.jpg https://endeavourvision.com/wp-content/uploads/2018/03/news-medartis-2018-13.jpg https://endeavourvision.com/medical-device-maker-medartis-plans-swiss-ipo/ 2023-04-12T13:11:48+00:00 https://endeavourvision.com/wp-content/uploads/2018/02/news-medartis-2018-14.jpg https://endeavourvision.com/wp-content/uploads/2018/02/news-medartis-2018-14.jpg https://endeavourvision.com/symetis-and-boston-scientific-reach-usd-435-million-purchase-agreement/ 2023-04-12T13:19:22+00:00 https://endeavourvision.com/wp-content/uploads/2017/03/news-symetis-boston-scientific.jpg https://endeavourvision.com/wp-content/uploads/2017/03/news-symetis-boston-scientific.jpg https://endeavourvision.com/gynesonics-announces-publications-on-healthcare-economic-analyses-demonstrating-significant-facility-and-payer-cost-savings/ 2023-04-12T13:32:58+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/gynesonics-receives-fda-clearance-to-market-next-generation-sonata-system-2-1/ 2023-04-12T13:56:28+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/sonata-system-assists-facilities-impacted-by-the-covid-19-pandemic-in-restarting-elective-gynecologic-procedures/ 2023-04-12T14:07:09+00:00 https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/relievant-announces-completion-of-58m-series-e-financing-to-support-us-commercialization/ 2023-04-12T14:10:44+00:00 https://endeavourvision.com/wp-content/uploads/2018/06/news-relievant-2018-8.jpg https://endeavourvision.com/wp-content/uploads/2018/06/news-relievant-2018-8.jpg https://endeavourvision.com/how-endeavour-became-a-reference-in-medtech-an-interview-with-bilan/ 2023-04-12T14:16:11+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/news-bilan_interview-2018-5.jpg https://endeavourvision.com/wp-content/uploads/2018/07/news-bilan_interview-2018-5.jpg https://endeavourvision.com/molecular-partners-reports-changes-in-ownership/ 2023-04-12T14:20:59+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-header-molecular-partners-01.jpg https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/symetis-announces-intention-to-float-on-six-swiss-exchange/ 2023-04-12T14:23:42+00:00 https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/symetis-receives-ce-mark-approval-for-transfemoral-transcatheter-aortic-heart-valve-system-acurate-neo-and-launches-product-with-first-commercial-implantations/ 2023-04-12T14:35:06+00:00 https://endeavourvision.com/wp-content/uploads/2015/09/news-symetis.jpg https://endeavourvision.com/endeavour-vision-interview-with-agefi-impact-of-covid-19-on-investments-in-starts-ups-the-medtech-sector-and-the-firms-investment-strategy/ 2023-04-12T15:34:59+00:00 https://endeavourvision.com/wp-content/uploads/2020/04/EV_site-BVogel_2.jpg https://endeavourvision.com/wp-content/uploads/2020/04/EV_site-BVogel_2.jpg https://endeavourvision.com/gynesonics-names-industry-veteran-skip-baldino-president-and-ceo-announces-25m-financing-to-expand-worldwide-commercialization/ 2023-04-13T09:58:51+00:00 https://endeavourvision.com/wp-content/uploads/2023/04/CEO-and-LOGO_Gynesonics.jpg https://endeavourvision.com/wp-content/uploads/2023/04/CEO-and-LOGO_Gynesonics.jpg https://endeavourvision.com/medartis-announces-completion-of-a-chf-30-million-capital-increase-to-finance-its-additional-stake-in-keri-medical/ 2023-05-02T09:31:51+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/gynesonics-announces-75-million-financing/ 2023-05-04T14:04:15+00:00 https://endeavourvision.com/wp-content/uploads/2019/01/news-gynesonics_sonata_2019_16.jpg https://endeavourvision.com/wp-content/uploads/2017/12/news-gynesonics-02.jpg https://endeavourvision.com/relievant-announces-reimbursement-codes-and-apc-assignment-for-the-intracept-procedure/ 2023-05-04T14:11:52+00:00 https://endeavourvision.com/wp-content/uploads/2019/08/news-header-relievant-02.jpg https://endeavourvision.com/wp-content/uploads/2019/08/news-header-relievant-02.jpg https://endeavourvision.com/molecular-partners-confirms-ultra-potent-inhibition-of-sars-cov-2-live-virus-by-anti-covid-19-darpin-candidates/ 2023-05-04T14:19:11+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/relievant-announces-level-1-intracept-study-stopped-early-for-superiority/ 2023-05-04T14:46:04+00:00 https://endeavourvision.com/wp-content/uploads/2019/01/news-relievant_2019_18.jpg https://endeavourvision.com/wp-content/uploads/2019/01/news-relievant_2019_18.jpg https://endeavourvision.com/patrick-amstutz-appointed-as-molecular-partners-chief-executive-officer/ 2023-05-04T14:52:45+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/endeavour-vision-accelerates-investments-in-switzerland-and-the-us-an-interview-with-agefi/ 2023-05-04T14:54:05+00:00 https://endeavourvision.com/wp-content/uploads/2018/08/news-agefi_interview-2018-3.jpg https://endeavourvision.com/wp-content/uploads/2018/08/news-agefi_interview-2018-3.jpg https://endeavourvision.com/interview-with-rob-barmann-senior-investment-director-at-endeavour-vision/ 2023-05-04T15:06:47+00:00 https://endeavourvision.com/wp-content/uploads/2019/07/news-endeavour_barmann_2019_7.jpg https://endeavourvision.com/wp-content/uploads/2019/07/news-endeavour_barmann_2019_7.jpg https://endeavourvision.com/molecular-partners-total-offer-size-of-ipo-reaches-chf-106-2-million-after-partial-exercise-of-ipo-over-allotment-option/ 2023-05-04T15:11:11+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/molecular-partners-has-successfully-priced-its-ipo-post-re-launch-and-lists-its-shares-on-six-swiss-exchange/ 2023-05-08T07:41:33+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/endeavour-establishes-largest-medtech-fund-in-europe-at-eur-250m/ 2023-05-08T07:44:46+00:00 https://endeavourvision.com/wp-content/uploads/2016/03/news-endeavour-vision.jpg https://endeavourvision.com/wp-content/uploads/2016/03/news-endeavour-vision.jpg https://endeavourvision.com/interview-with-kevin-hykes-president-ceo-at-relievant/ 2023-05-08T08:06:53+00:00 https://endeavourvision.com/wp-content/uploads/2019/06/news-relievant-kevin-hykes-02.jpg https://endeavourvision.com/wp-content/uploads/2019/06/news-relievant-kevin-hykes-02.jpg https://endeavourvision.com/gynesonics-receives-fda-clearance-to-market-sonata-system/ 2023-05-08T08:12:38+00:00 https://endeavourvision.com/wp-content/uploads/2018/08/news-gynesonics-2018-4.jpg https://endeavourvision.com/wp-content/uploads/2018/08/news-gynesonics-2018-4.jpg https://endeavourvision.com/molecular-partners-and-amgen-announce-strategic-collaboration-in-immuno-oncology/ 2023-05-08T08:28:08+00:00 https://endeavourvision.com/wp-content/uploads/2018/12/news-molecular_amgen-2018-1.jpg https://endeavourvision.com/wp-content/uploads/2018/12/news-molecular_amgen-2018-1.jpg https://endeavourvision.com/relievant-medsystems-announces-more-than-10000-patients-treated-with-the-intracept-procedure-for-vertebrogenic-low-back-pain/ 2023-05-10T07:04:11+00:00 https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/relievant-medsystems-raises-50-million-to-advance-the-treatment-for-chronic-vertebrogenic-low-back-pain/ 2023-06-21T07:54:25+00:00 https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/endeavour-vision-aims-to-be-among-the-world-leaders-an-interview-with-agefi/ 2023-06-26T08:14:15+00:00 https://endeavourvision.com/wp-content/uploads/2018/08/news-agefi_interview-2018-3.jpg https://endeavourvision.com/wp-content/uploads/2018/08/news-agefi_interview-2018-3.jpg https://endeavourvision.com/impact-of-covid-19-on-medtech-innovation-investing/ 2023-06-26T08:18:39+00:00 https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-image_BVogel_EV-1.jpg https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-image_BVogel_EV-1.jpg https://endeavourvision.com/endeavour-interviewed-by-le-temps-for-investors-health-has-become-a-refuge/ 2023-06-26T08:23:19+00:00 https://endeavourvision.com/wp-content/uploads/2020/05/letemps2.jpg https://endeavourvision.com/wp-content/uploads/2020/05/letemps2.jpg https://endeavourvision.com/gynesonics-raises-43-million-in-equity-financing-endeavour-vision-and-abingworth-lead-funding/ 2023-06-26T08:31:07+00:00 https://endeavourvision.com/wp-content/uploads/2019/03/news-header-sonata-01.jpg https://endeavourvision.com/wp-content/uploads/2019/03/news-header-sonata-01.jpg https://endeavourvision.com/gynesonics-announces-publication-of-final-sonata-ida-pivotal-trial-results-in-the-journal-obstetrics-and-gynecology/ 2023-06-26T08:36:06+00:00 https://endeavourvision.com/wp-content/uploads/2019/03/news-gynesonics_2019_19.jpg https://endeavourvision.com/wp-content/uploads/2019/03/news-gynesonics_2019_19.jpg https://endeavourvision.com/dental-products-sector-review-qa-with-endeavour-visions-investment-director-fernando-pacheco/ 2023-07-14T13:12:27+00:00 https://endeavourvision.com/wp-content/uploads/2023/07/news-featured-image_fernando-pacheco.jpg https://endeavourvision.com/wp-content/uploads/2023/07/news-featured-image_fernando-pacheco.jpg https://endeavourvision.com/nuvaira-receives-french-innovation-funding-for-nuvaira-airflow-3-pivotal-trail/ 2023-07-24T15:48:36+00:00 https://endeavourvision.com/wp-content/uploads/2019/05/news-header-nuvaira-01.jpg https://endeavourvision.com/wp-content/uploads/2019/05/news-header-nuvaira-01.jpg https://endeavourvision.com/endeavour-vision-invests-in-surgical-bone-repairs-specialist-medartis/ 2023-07-24T15:54:56+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/polares-raises-25m-to-bring-its-hemi-replacement-mitral-valve-to-the-clinic/ 2023-07-24T16:00:34+00:00 https://endeavourvision.com/wp-content/uploads/2018/07/news-polares-2018-7.jpg https://endeavourvision.com/wp-content/uploads/2018/07/news-polares-2018-7.jpg https://endeavourvision.com/gynesonics-announces-results-from-pivotal-ide-trial-for-incision-free-treatment-for-uterine-fibroids/ 2023-07-24T16:08:31+00:00 https://endeavourvision.com/wp-content/uploads/2018/01/news-gynesonics-2018-17.jpg https://endeavourvision.com/wp-content/uploads/2018/01/news-gynesonics-2018-17.jpg https://endeavourvision.com/first-patient-enrolled-in-phase-iii-study-of-abicipar-molecular-partners-receives-usd-15-million-milestone-payment/ 2023-07-24T16:11:27+00:00 https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/wp-content/uploads/2017/05/news-molecular-partners.jpg https://endeavourvision.com/virtual-incision-extends-series-c-round-with-additional-30m-funding/ 2023-09-19T16:00:12+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/gynesonics-incision-free-sonata-procedure-for-the-treatment-of-uterine-fibroids-reaches-patient-milestone/ 2023-10-18T10:06:33+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/gynesonics-announces-67m-financing-to-expand-commercialization-of-sonata-procedure/ 2023-11-02T14:28:22+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/venturemed-receives-transitional-pass-through-payment-tpt-for-flex-vessel-preptm-system/ 2023-11-09T16:55:33+00:00 https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/boston-scientific-closes-acquisition-of-relievant-medsystems-inc/ 2023-11-20T12:09:39+00:00 https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/mira-proceeds-to-fda-substantive-review-for-market-authorization/ 2023-11-20T12:16:48+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/ai-in-care-delivery-recent-past-and-promises-for-the-future/ 2023-12-06T10:42:47+00:00 https://endeavourvision.com/wp-content/uploads/2022/02/news-featured-image_DanielVdBergh-EV700x448.jpg https://endeavourvision.com/wp-content/uploads/2022/02/news-featured-image_DanielVdBergh-EV700x448.jpg https://endeavourvision.com/virtual-incisions-miniaturized-surgical-robot-en-route-to-the-international-space-station-for-testing-of-long-range-remote-capabilities/ 2024-01-30T17:41:56+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/virtual-incision-receives-fda-authorization-for-the-mira-surgical-system-as-the-first-miniaturized-robotic-assisted-surgery-device/ 2024-02-26T09:01:21+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/nalu-medical-inc-announces-65-million-equity-financing-to-advance-treatment-for-chronic-neuropathic-pain/ 2024-02-27T15:08:24+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/kenbi-acquires-major-homecare-provider-benefitting-from-liquid-ma-opportunities-and-taking-digital-disruptor-lead/ 2024-02-27T15:18:23+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_kenbi_700x447_2.jpg https://endeavourvision.com/nalu-medical-inc-announces-positive-results-of-us-spinal-cord-stimulation-clinical-study-in-pain-physician-journal/ 2024-02-27T15:22:23+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/boston-scientific-announces-agreement-to-acquire-relievant-medsystems-inc/ 2024-02-27T15:24:34+00:00 https://endeavourvision.com/wp-content/uploads/2023/04/news-featured-img_relievant_700x447_2-400x255-1.jpg https://endeavourvision.com/viewpoint-on-the-fda-marketing-authorization-for-mira/ 2024-03-01T13:46:14+00:00 https://endeavourvision.com/wp-content/uploads/2024/03/news-featured-image_fernando-pacheco_VIC.jpg https://endeavourvision.com/miach-orthopaedics-raises-20-million-in-series-b-extension/ 2024-04-03T12:48:59+00:00 https://endeavourvision.com/wp-content/uploads/2023/01/news-featured-img_Miach_700x447.jpg https://endeavourvision.com/wp-content/uploads/2023/01/news-featured-img_Miach_700x447.jpg https://endeavourvision.com/medartis-successfully-places-chf-115-8-million-convertible-bonds-due-2031/ 2024-04-04T15:39:11+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/sophia-genetics-announces-unilabs-is-using-its-ai-technology-to-detect-homologous-recombination-deficiency-hrd/ 2024-04-29T13:53:36+00:00 https://endeavourvision.com/wp-content/uploads/2021/07/news-featured-img_sophia_700x447_2.jpg https://endeavourvision.com/cequr-simplicity-a-wearable-mealtime-insulin-delivery-device-obtains-fda-clearance-for-4-days-of-wear-to-further-simplify-diabetes-management/ 2024-06-20T19:45:44+00:00 https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/matthias-schupp-appointed-as-ceo-of-medartis/ 2024-07-09T08:26:33+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/intelycare-appoints-industry-leader-matthew-levesque-as-ceo/ 2024-07-18T20:03:23+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/ekestra-medical-technologies-announces-196-million-oversubscribed-financing-round/ 2024-07-29T16:05:17+00:00 https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/health-catalyst-finalizes-acquisition-of-leading-care-management-company-lumeon/ 2024-08-12T20:21:27+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_lumenon_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/08/news-featured-image_lumeon2.jpg https://endeavourvision.com/johnson-johnson-to-acquire-v-wave/ 2024-08-20T15:07:22+00:00 https://endeavourvision.com/wp-content/uploads/2018/04/news-vwave-2018-12.jpg https://endeavourvision.com/wp-content/uploads/2018/04/news-vwave-2018-12.jpg https://endeavourvision.com/interview-with-tom-west-ceo-of-nalu-medical/ 2024-08-27T08:33:06+00:00 https://endeavourvision.com/wp-content/uploads/2024/08/news-featured-image_Thomas_West_Nalu.jpg http://endeavourvision.com/wp-content/uploads/2024/08/Image-newsletter.png https://endeavourvision.com/hologic-to-acquire-gynesonics-for-350-million/ 2024-10-15T06:16:02+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/hologic-complete-acquisition-gynesonics/ 2025-01-06T23:43:47+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_gynesonics_700x447_2.jpg https://endeavourvision.com/from-investment-to-acquisition-gynesonics-journey-in-transforming-womens-health-qa-with-endeavour-vision-partner-alexander-schmitz/ 2025-01-17T15:41:19+00:00 https://endeavourvision.com/wp-content/uploads/2025/01/Gynesonics_Alex-Schmitz_news.jpg https://endeavourvision.com/wp-content/uploads/2025/01/Gynesonics_Alex-Schmitz_news.jpg https://endeavourvision.com/cequr-closes-a-120m-equity-financing-to-drive-commercial-growth/ 2025-01-21T12:58:17+00:00 https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/06/news-featured-img_cequr_700x447_2.jpg https://endeavourvision.com/kestra-medical-technologies-files-for-ipo-amidst-revenue-growth/ 2025-02-14T10:42:13+00:00 https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/wp-content/uploads/2022/08/news-featured-img_kestra_700x447.jpg https://endeavourvision.com/redefining-wcds-a-conversation-with-kestras-ceo/ 2025-02-18T15:20:26+00:00 https://endeavourvision.com/wp-content/uploads/2025/02/CEO-and-LOGO_kestra.jpg https://endeavourvision.com/wp-content/uploads/2025/02/CEO-and-LOGO_kestra.jpg https://endeavourvision.com/venturemed-group-closes-28m-series-c-funding-to-accelerate-commercial-adoption-and-expand-indications-for-the-flex-vptm-system/ 2025-10-30T18:17:50+00:00 https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/wp-content/uploads/2017/08/news-venturemed-group.jpg https://endeavourvision.com/medartis-acquires-remaining-53-stake-in-kerimedical/ 2025-11-09T16:51:36+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/boston-scientific-announces-agreement-to-acquire-nalu-medical-inc/ 2025-11-09T17:01:02+00:00 https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/12/news-featured-img_nalu_700x447_2.jpg https://endeavourvision.com/virtual-incision-appoints-jim-alecxih-as-chief-executive-officer/ 2025-11-09T17:04:08+00:00 https://endeavourvision.com/wp-content/uploads/2021/11/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2025/06/news-featured-img_vic_700x447_2.jpg https://endeavourvision.com/medartis-appoints-peter-hackel-as-new-chief-financial-officer/ 2025-11-25T09:32:14+00:00 https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/12/news-featured-img_medartis_700x447_2.jpg https://endeavourvision.com/intelycare-acquires-carerev-to-create-comprehensive-workforce-staffing-platform-for-health-systems/ 2026-01-08T23:37:04+00:00 https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2021/09/news-featured-img_intelycare_700x447_2.jpg https://endeavourvision.com/fda-approves-updated-label-for-miach-orthopaedics-bear-implant-to-include-significantly-lower-risk-of-osteoarthritis/ 2026-01-14T20:17:19+00:00 https://endeavourvision.com/wp-content/uploads/2026/01/news-featured-img_Miach2026_700x447.jpg https://endeavourvision.com/wp-content/uploads/2026/01/news-featured-img_Miach2026_700x447.jpg https://endeavourvision.com/polares-medical-raises-50-million-series-c-to-advance-u-s-expansion-of-mrace-following-strong-clinical-results/ 2026-03-08T13:20:50+00:00 https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-img_polares_700x447_2.jpg https://endeavourvision.com/wp-content/uploads/2020/06/news-featured-img_polares_700x447_2.jpg https://endeavourvision.com/miach-orthopaedics-names-jamal-rushdy-president-ceo/ 2026-05-12T21:43:54+00:00 https://endeavourvision.com/wp-content/uploads/2026/01/news-featured-img_Miach2026_700x447.jpg https://endeavourvision.com/wp-content/uploads/2026/01/news-featured-img_Miach2026_700x447.jpg